Financhill
Sell
32

SOMMY Quote, Financials, Valuation and Earnings

Last price:
$14.65
Seasonality move :
0.68%
Day range:
$14.65 - $14.65
52-week range:
$9.95 - $16.85
Dividend yield:
0%
P/E ratio:
8.28x
P/S ratio:
0.28x
P/B ratio:
0.72x
Volume:
881
Avg. volume:
1.1K
1-year change:
35.92%
Market cap:
$4.7B
Revenue:
$17.1B
EPS (TTM):
$1.72

Earnings Data

Next earnings date for SOMMY
Feb 02
2026
Most recent earnings per share
$0.92
Beat by $0.92
(Nov 4/2025)
Consensus Estimate
--
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SOMMY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/04/2025 Q3 -- $3.9B $0.92 -- --
08/01/2025 Q2 -- $3.6B -$0.10 -- --
03/31/2025 Q1 -- $4.6B $0.20 -- --
12/31/2024 Q4 -- $4.4B $0.70 -- --
09/30/2024 Q3 -- $4.2B -$0.63 -- --
06/30/2024 Q2 -- $3.9B $0.48 -- --
03/31/2024 Q1 -- $4.3B -$4.16 -- --
12/31/2023 Q4 -- $4.2B -$0.69 -- --
09/30/2023 Q3 -- $4.3B -$0.91 -- --
06/30/2023 Q2 -- $4.1B -$0.74 -- --
03/31/2023 Q1 -- $4.8B -$1.23 -- --
12/31/2022 Q4 -- $5.2B -$0.45 -- --
09/30/2022 Q3 -- $5.5B $0.24 -- --
06/30/2022 Q2 -- $6B $1.65 -- --
03/31/2022 Q1 -- $6.3B $0.75 -- --
12/31/2021 Q4 -- $6.3B $1.20 -- --
09/30/2021 Q3 -- $6.2B $1.48 -- --
06/30/2021 Q2 -- $5.8B $1.00 -- --
03/31/2021 Q1 -- $6.1B $0.69 -- --
12/31/2020 Q4 -- $5.7B $0.66 -- --
09/30/2020 Q3 -- $5.1B $0.15 -- --
06/30/2020 Q2 -- $4.7B -$0.21 -- --
03/31/2020 Q1 -- $5.3B -$0.19 -- --
12/31/2019 Q4 -- $5B $0.22 -- --
09/30/2019 Q3 -- $5.2B $0.43 -- --
06/30/2019 Q2 -- $5B $0.40 -- --
03/31/2019 Q1 -- $5.5B $0.81 -- --
12/31/2018 Q4 -- $5.2B $0.74 -- --
09/30/2018 Q3 -- $5.1B $0.86 -- --
06/30/2018 Q2 -- $5B $0.84 -- --
03/31/2018 Q1 -- -- $0.71 -- --
12/31/2017 Q4 -- $5B $0.85 -- --
09/30/2017 Q3 -- $4.8B $1.19 -- --
06/30/2017 Q2 -- $4.6B $0.93 -- --
03/31/2017 Q1 -- $5B $0.81 -- --
12/31/2016 Q4 -- $4.5B $1.01 -- --
09/30/2016 Q3 -- $4.3B $0.21 -- --
06/30/2016 Q2 -- $4.2B $0.35 -- --
03/31/2016 Q1 -- $4.5B -$0.08 -- --
12/31/2015 Q4 -- $4.1B $0.60 -- --

Sumitomo Chemical Co., Ltd. Earnings Questions

  • How Much did Sumitomo Chemical Co., Ltd. Generate in Revenue Last Quarter?

    Sumitomo Chemical Co., Ltd. reported $3.9B worth of top line sales in its most recent quarter.

  • Did Sumitomo Chemical Co., Ltd. Beat Earnings Last Quarter?

    Sumitomo Chemical Co., Ltd. announced earnings per share of $0.92 which represents a beat of analyst forecast a -- per share.

  • Is Sumitomo Chemical Co., Ltd. Profitable?

    Sumitomo Chemical Co., Ltd. reported $1.2B that represents $3.78 per share over the last quarter.

  • What is the Analyst Consensus for Sumitomo Chemical Co., Ltd. EPS Next Year?

    Sumitomo Chemical Co., Ltd.'s earnings are forecast to grow from $0.77 per share to -- per share next year representing an increase of --.

  • When is Sumitomo Chemical Co., Ltd.'s Earnings Date?

    Sumitomo Chemical Co., Ltd.'s next earnings date is February 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 23

Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.

Buy
60
ZBIO alert for Dec 23

Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.

Buy
54
UNF alert for Dec 23

UniFirst Corp. [UNF] is up 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock